An Assessment of LRRK2 Serine 935 Phosphorylation in Human Peripheral Blood Mononuclear Cells in Idiopathic Parkinson’s Disease and G2019S LRRK2 Cohorts

The phosphorylated form of LRRK2, pS935 LRRK2, has been proposed as a target modulation biomarker for LRRK2 inhibitors. The primary aim of the study was to characterize and qualify this biomarker for therapeutic trials of LRRK2 inhibitors in Parkinson’s disease (PD). To this end, analytically valida...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:J Parkinsons Dis
Glavni autori: Padmanabhan, Shalini, Lanz, Thomas A., Gorman, Donal, Wolfe, Michele, Joyce, Alison, Cabrera, Carlos, Lawrence-Henderson, Rosemary, Levers, Najah, Joshi, Neal, Ma, Thong C., Liong, Christopher, Narayan, Sushma, Alcalay, Roy N., Hutten, Samantha J., Baptista, Marco A.S., Merchant, Kalpana
Format: Artigo
Jezik:Inglês
Izdano: IOS Press 2020
Teme:
Research Report
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7242833/
https://ncbi.nlm.nih.gov/pubmed/32007961
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JPD-191786
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items